Evolutionary reversion of live viral vaccines: Can genetic engineering subdue it?
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Attenuated, live viral vaccines have been extraordinarily successful in protecting against many diseases. The main drawbacks in their development and use have been reliance on an unpredictable method of attenuation and the potential for evolutionary reversion to high virulence. Methods of genetic engineering now provide many safer alternatives to live vaccines, so if live vaccines are to compete with these alternatives in the future, they must either have superior immunogenicity or they must be able to overcome these former disadvantages. Several live vaccine designs that were historically inaccessible are now feasible because of advances in genome synthesis. Some of those methods are addressed here, with an emphasis on whether they enable predictable levels of attenuation and whether they are stable against evolutionary reversion. These new designs overcome many of the former drawbacks and position live vaccines to be competitive with alternatives. Not only do new methods appear to retard evolutionary reversion enough to prevent vaccine-derived epidemics, but it may even be possible to permanently attenuate live vaccines that are transmissible but cannot evolve to higher virulence under prolonged adaptation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Virus attenuation by genome-scale changes in codon pair bias
Coleman, J. R., Papamichail, D., Skiena, S., Futcher, B., Wimmer, E., & Mueller, S. (2008) · Science · doi:10.1126/science.1155761 · Cited by 715 · cited 1×
“Thus the design of an attenuated strain to avoid strict genetic reversal of the changes does not ensure the absence of an evolutionary reversal of the attenuation.”
BackgroundThe distribution of fitness effects caused by single-nucleotide substitutions in an RNA virus.
Sanjuán, R., Moya, A., & Elena, S. F. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400146101 · Cited by 582 · cited 1×
“First, the fitness effects of random mutations vary greatly, so the fitness decline from, say, 10 random mutations might be due primarily to just one or two of those mutations, potentially allowing for easy recovery (Sanjuan, Moya, and Elena 2004; Domingo-Calap, Cuevas, and Sanjuan 2009).”
BackgroundFitness of RNA virus decreased by Muller’s ratchet
Chao, L. (1990) · Nature · doi:10.1038/348454a0 · Cited by 488 · cited 1×
“It has long been known that the fixation of random mutations in a population will lead to a decrease in average population fitness, and a simple way to fix random mutations is to force the population through a series of extreme bottlenecks (Chao 1990; Elena et al. 2001; Bull et al. 2003).”
BackgroundLive attenuated influenza virus vaccines by computer-aided rational design
Mueller, S., Coleman, J. R., Papamichail, D., Ward, C. B., Nimnual, A., Futcher, B., Skiena, S., & Wimmer, E. (2010) · Nature Biotechnology · doi:10.1038/nbt.1636 · Cited by 275
Atkinson, N. J., Witteveldt, J., Evans, D. J., & Simmonds, P. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku075 · Cited by 192
Tulloch, F., Atkinson, N. J., Evans, D. J., Ryan, M. D., & Simmonds, P. (2014) · eLife · doi:10.7554/elife.04531 · Cited by 178
Burns, C. C., Campagnoli, R., Shaw, J., Vincent, A., Jorba, J., & Kew, O. (2009) · Journal of Virology · doi:10.1128/jvi.00508-09 · Cited by 170
Martrus, G., Nevot, M., Andres, C., Clotet, B., & Martinez, M. A. (2013) · Retrovirology · doi:10.1186/1742-4690-10-78 · Cited by 85 · cited 3×
“, 2009 Bull, Molineux, and Wilke 2012; Martrus et al.”
BackgroundInfluential
Cited by
COVID-19 vaccine development and a potential nanomaterial path forward
Shin, M. D., Shukla, S., Chung, Y. H., Beiss, V., Chan, S. K., Ortega-Rivera, O. A., Wirth, D. M., Chen, A., Sack, M., Pokorski, J. K., et al. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0737-y · Cited by 659
COVID-19 vaccines: The status and perspectives in delivery points of view
Chung, J. Y., Thone, M. N., & Kwon, Y. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.011 · Cited by 375
Experimental evolution as a high-throughput screen for genetic adaptations
Cooper, V. S. (2018) · mSphere · doi:10.1128/msphere.00121-18 · Cited by 126
Cell penetrating peptide: A potent delivery system in vaccine development
Hasannejad-Asl, B., Pooresmaeil, F., Takamoli, S., Dabiri, M., & Bolhassani, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1072685 · Cited by 40
Metadata
- Authors
- Bull, J. J.
- Venue
- Virus Evolution
- Publisher
- Oxford University Press (OUP)
- Published
- 2015
- Volume
- 1
- Issue
- 1
- Pages
- vev005
- ISSN
- 2057-1577 (ISSN-L)
- OpenAlex
- W2372552287
- Cited by
- 79
- References
- 8
- FWCI
- 2.47
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evolutionary reversion of live viral vaccines: Can genetic engineering subdue it? https://app.cochat.ai/papers/10.1093/ve/vev005
- The paper
- Bull, J. J. (2015). Evolutionary reversion of live viral vaccines: Can genetic engineering subdue it? Virus Evolution. https://doi.org/10.1093/ve/vev005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.